PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline COMMENT

Authors:
  • WTWilliam P. Tew
    William P. Tew
  • CLChristina Lacchetti
    Christina Lacchetti
  • AEAnnie Ellis
    Annie Ellis
  • KMKathleen Maxian
    Kathleen Maxian
  • SBSusana Banerjee
    Susana Banerjee
  • MBMichael Bookman
    Michael Bookman
  • MJMonica Brown Jones
    Monica Brown Jones
  • JLJung-Min Lee
    Jung-Min Lee
  • SLStéphanie Lheureux
    Stéphanie Lheureux
  • JLJoyce F. Liu
    Joyce F. Liu
  • KMKathleen N. Moore
    Kathleen N. Moore
  • CMCarolyn Muller
    Carolyn Muller

Abstract
No abstract available